imaging plasmodium liver stages drive next-generation antimalarial drug discovery 
malaria drug development focuses parasite stages detected red blood cells even though achieve eradication next-generation drugs active erythrocytic exo-erythrocytic forms preferable applied multifactorial approach set > commercially available compounds previously demonstrated blood-stage activity median inhibitory concentration < micromolar identified chemical scaffolds potent activity forms screen identified imidazolopiperazine scaffold series highly enriched among compounds active plasmodium liver stages orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection milligrams/kilogram rodent models malaria shows potent vivo blood-stage therapeutic activity open-source chemical tools resulting effort provide starting points future drug discovery programs well opportunities researchers investigate biology exo-erythrocytic forms 
